Effects of medicare part D on disparity implications of medication therapy management eligibility criteria

American Health and Drug Benefits

Volumn 7, Issue 6, 2014, Pages 346-357

  Wang, Junling ^a   Qiao, Yanru ^a   Shih, Ya Chen Tina ^b   Jamison, Joellen Jarrett ^c   Spivey, Christina A ^a   Li, Liyuan ^a   Wan, Jim Y ^c   White Means, Shelley I ^a   Dagogo Jack, Samuel ^c   Cushman, William C ^d   Chisholm Burns, Marie ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BEHAVIOR CHANGE; BLACK PERSON; CAUCASIAN; CONCEPTUAL FRAMEWORK; DEMOGRAPHY; EDUCATION; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEALTH SERVICE; HEALTH STATUS; HISPANIC; HOSPITAL PHYSICIAN; HUMAN; LOWEST INCOME GROUP; MALE; MEDICARE; MEDICATION THERAPY MANAGEMENT; MINORITY GROUP; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; RACE DIFFERENCE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; VERY ELDERLY;

EID: 84907550085     PISSN: 19422962     EISSN: 19422970     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; Medicare prescription drug benefit. Final rule. Fed Regist. 2005;70:4193-4585.
2. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication Therapy Management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003). 2005;45: 573-579.
3. Centers for Medicare & Medicaid Services. 2011 Medicare Part D Medication Therapy Management (MTM) programs. June 30, 2011. www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/mtmfactsheet2011063011final.pdf. Accessed July 6, 2014.
4. Briesacher B, Limcangco R, Gaskin D. Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev. Winter 2003-2004;25:63-76.
5. Schore J, Brown R, Lavin B. Racial disparities in prescription drug use among dually eligible beneficiaries. Health Care Financ Rev. Winter 2003-2004;25:77-90.
6. Wang J, Noel JM, Zuckerman IH, et al. Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Med Care Res Rev. 2006;63:742-763.
7. Wang J, Dong Z, Hong SH, Suda KJ. A comparison of direct medical costs across racial and ethnic groups among children with cancer. Curr Med Res Opin. 2008;24: 847-858.
8. Wang J, White-Means SI, Hufstader MA, Walker GD. The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors. Curr Med Res Opin. 2007;23:853-863.
9. Wang J, Zuckerman IH, Miller NA, et al. Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res. 2007;42:1499-1519.
10. Wang J, Mullins CD, Brown LM, et al. Disparity implications of Medicare eligibility criteria for medication therapy management services. Health Serv Res. 2010;45: 1061-1082.
11. Wang J, Qiao Y, Tina Shih YC, et al. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. Res Social Adm Pharm. 2014; 10:106-125.
12. Centers for Medicare & Medicaid Services. Medicare Current Beneficiary Survey (MCBS). Updated July 24, 2014. www.cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/index.html?redirect=/mcbs/. Accessed July 24, 2014.
13. US Food and Drug Administration. Orange Book data files. Updated July 18, 2014. www.fda.gov/drugs/informationondrugs/ucm129689.htm. Accessed July 24, 2014.
14. Andersen RM, Rice TH, Kominski GF, eds. Changing the U.S. Health Care System: Key Issues in Health Services Policy and Management. 3rd ed. San Francisco, CA: Jossey-Bass; 2007.
15. Iezzoni LI, ed. Risk Adjustment for Measuring Healthcare Outcomes. 2nd ed. Chicago, IL: Health Administration Press; 1997.
16. Agency for Healthcare Research and Quality. Clinical Classifications Software (CCS) for ICD-9-CM. July 2014. Updated July 29, 2014. www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp. Accessed July 6, 2014.
17. Daniel GW, Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for Medicare medication therapy management programs. J Manag Care Pharm. 2007;13:142-154.
18. Pharmacy Quality Alliance. PQA performance measures. http://pqaalliance.org/measures/default.asp. Accessed July 6, 2014.
19. Centers for Medicare & Medicaid Services. 2010 Medicare Part D Medication Therapy Management (MTM) programs. June 8, 2010. www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/MTMFactSheet_2010_06-2010_final.pdf. Accessed July 6, 2014.
20. Bureau of Labor Statistics. Consumer Price Index. www.bls.gov/cpi/. Accessed July 6, 2014.
21. Buis ML. Stata tip 87: interpretation of interactions in nonlinear models. Stata J. 2010;10:305-308.
22. Liu FX, Alexander GC, Crawford SY, et al. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res. 2011;46:1104-1123.
23. Afendulis CC, He Y, Zaslavsky AM, et al. The impact of Medicare Part D on hospitalization rates. Health Serv Res. 2011;46:1022-1038.
24. Kaestner R, Khan N. Medicare Part D and its effect on the use of prescription drugs, use of other health care services and health of the elderly. The National Bureau of Economic Research Working Paper. www.nber.org/papers/w16011. Accessed September 5, 2014.
25. Chen J, Rizzo JA, Ortega AN. Racial and ethnic differences in drug expenditures and access under Medicare Part D. J Health Care Poor Underserved. 2011;22:1059-1074.
26. Mahmoudi E, Jensen GA. Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending? Health Serv Res. 2014;49:502-525.
27. Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22:479-485.
28. Shi L. Vulnerable populations and health insurance. Med Care Res Rev. 2000;57: 110-134.
29. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Relationship between quality of care and racial disparities in Medicare health plans. JAMA. 2006;296:1998-2004.
30. Cook DM, Moulton PV, Sacks TM, Yang W. Self-reported responses to medication therapy management services for older adults: analysis of a 5-year program. Res Social Adm Pharm. 2012;8:217-227.
31. Heckler MM. Report of the Secretary’s Task Force on Black and Minority Health, Department of Health and Human Services, 1985. http://minorityhealth.hhs.gov/assets/pdf/checked/1/ANDERSON.pdf. Accessed September 5, 2014.
32. US Department of Health and Human Services. HHS action plan to reduce racial and ethnic health disparities: a nation free of disparities in health and health care. http://minorityhealth.hhs.gov/npa/files/Plans/HHS/HHS_Plan_complete.pdf. Accessed July 6, 2014.
33. Koh HK. A 2020 vision for healthy people. N Engl J Med. 2010;362:1653-1656.
34. National Institute on Minority Health and Health Disparities. About NIMHD: vision & mission. www.nimhd.nih.gov/about/visionMission.html. Accessed July 6, 2014.
35. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med. 2009;361:109-112.
36. LaVeist TA. Beyond dummy variables and sample selection: what health services researchers ought to know about race as a variable. Health Serv Res. 1994;29:1-16.
37. Waldo DR. Accuracy and bias of race/ethnicity codes in the Medicare enrollment database. Health Care Financ Rev. Winter 2004-2005;26:61-72.